Sona Saira Ramasastry
Direttore/Membro del Consiglio presso GLENMARK PHARMACEUTICALS LIMITED
Patrimonio netto: 820 073 $ in data 31/05/2024
Profilo
Sona Saira Ramasastry is the founder of Life Sciences Advisory LLC, which was founded in 2009.
She currently holds several positions as an independent director or member of the board of directors, including at Glenmark Pharmaceuticals Ltd., Vir Biotechnology, Inc., Mirum Pharmaceuticals, Inc., Pain Therapeutics, Inc., Elevian, Inc., DOT Therapeutics-2, Inc., and Day One Biopharmaceuticals, Inc. She is also a member of the Aspen Global Leadership Network and the European Prevention of Alzheimer's Dementia Consortium.
Ms. Ramasastry has held former positions as an independent director at Repros Therapeutics, Inc., Sangamo Therapeutics, Inc., Cassava Sciences, Inc., and 9 Meters Biopharma, Inc. She was also a financial analyst at Wasserstein Perella & Co., Inc. in 1997-1998.
Ms. Ramasastry received her undergraduate and graduate degrees from Stanford University and her graduate degree from the University of Cambridge.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 23/05/2024 | 50 485 ( 0.06% ) | 669 936 $ | 31/05/2024 | |
VIR BIOTECHNOLOGY, INC.
0.01% | 11/06/2024 | 14 619 ( 0.01% ) | 150 137 $ | 31/05/2024 |
| 05/06/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Posizioni attive di Sona Saira Ramasastry
| Società | Posizione | Inizio |
|---|---|---|
| GLENMARK PHARMACEUTICALS LIMITED | Direttore/Membro del Consiglio | 01/04/2019 |
| VIR BIOTECHNOLOGY, INC. | Direttore/Membro del Consiglio | 01/09/2019 |
| DAY ONE BIOPHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 01/03/2021 |
| MIRUM PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 02/06/2022 |
DOT Therapeutics-2, Inc.
 DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | Direttore/Membro del Consiglio | 12/04/2021 |
| European Prevention of Alzheimer's Dementia Consortium | Corporate Officer/Principal | - |
Elevian, Inc.
 Elevian, Inc. Pharmaceuticals: MajorHealth Technology Elevian, Inc. develops medicines that restore youthful regenerative capacity. The company was founded by Mark J. F. Allen, Sebastian Giwa, Peter H. Diamandis, Brock C. Reeve, and Luis Alvarez and is headquartered in Allston, MA. | Direttore/Membro del Consiglio | - |
Pain Therapeutics, Inc.
 Pain Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Pain Therapeutics, Inc. develops drugs. | Direttore/Membro del Consiglio | - |
| Aspen Global Leadership Network | Corporate Officer/Principal | - |
| ░░░░ ░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Precedenti posizioni note di Sona Saira Ramasastry
| Società | Posizione | Fine |
|---|---|---|
| ░░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░ ░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Sona Saira Ramasastry
| Stanford University | Graduate Degree |
| University of Cambridge | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 7 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| CASSAVA SCIENCES, INC. | Health Technology |
| GLENMARK PHARMACEUTICALS LIMITED | Health Technology |
| VIR BIOTECHNOLOGY, INC. | Health Technology |
| 9 METERS BIOPHARMA, INC. | Health Technology |
| MIRUM PHARMACEUTICALS, INC. | Health Technology |
| DAY ONE BIOPHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 10 |
|---|---|
Repros Therapeutics, Inc.
 Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Repros Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the development of drugs to treat hormonal and reproductive systems disorders. Its products include Enclomiphene and Proellex. The company was founded on August 20, 1987 and is headquartered in The Woodlands, TX. | Health Technology |
American Liver Foundation
 American Liver Foundation Miscellaneous Commercial ServicesCommercial Services American Liver Foundation engages in facilitating, advocating and promoting education, support, and research for the prevention, treatment, and cure of liver disease. It educates patients, policymakers and the public and provides grants to early-career researchers to help find a cure for all liver diseases. The company was founded in 1976 and is headquartered in New York, NY. | Commercial Services |
| Wasserstein Perella & Co., Inc. | |
| Life Sciences Advisory LLC | |
| Aspen Global Leadership Network | |
Akouos, Inc.
 Akouos, Inc. BiotechnologyHealth Technology Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna on March 7, 2016 and is headquartered in Boston, MA. | Health Technology |
Pain Therapeutics, Inc.
Pain Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Pain Therapeutics, Inc. develops drugs. | Health Technology |
Elevian, Inc.
Elevian, Inc. Pharmaceuticals: MajorHealth Technology Elevian, Inc. develops medicines that restore youthful regenerative capacity. The company was founded by Mark J. F. Allen, Sebastian Giwa, Peter H. Diamandis, Brock C. Reeve, and Luis Alvarez and is headquartered in Allston, MA. | Health Technology |
| European Prevention of Alzheimer's Dementia Consortium | |
DOT Therapeutics-2, Inc.
DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Sona Saira Ramasastry
